ISPE Announces 2016 – 2017 Chairman of the Board

Share Article

Michael Arnold was introduced as the 2016 – 2017 Chairman of the Board at ISPE’s Annual Meeting & Expo

Top: Michael Arnold addressing attendees at the 2016 ISPE Annual Meeting. Bottom: Michael Arnold (far right) with the Pierson family and Pfizer colleagues.

Top: Michael Arnold addressing attendees at the 2016 ISPE Annual Meeting. Bottom: Michael Arnold (far right) with the Pierson family and Pfizer colleagues.

ISPE has taken a leadership role in engaging with regulators in key areas such as drug shortages and quality metrics. I am enthusiastic about other recent efforts such as Women in Pharma and Industry Young Professionals.

The International Society for Pharmaceutical Engineering (ISPE) named Michael A. Arnold RPh as the 2016 – 2017 Chairman of International Board of Directors. Arnold was introduced as the new Chairman of the Board at ISPE’s Annual Meeting & Expo in Atlanta, Georgia.

Arnold has worked at Pfizer Inc. for 34 years in various leadership capacities, including Director of Pharmacy Operations and currently as Investigational Products Business Process Owner.

“I am very fortunate to work for Pfizer, said Arnold. “They have been very supportive of my ISPE activities and the work that ISPE does on behalf of the pharmaceutical industry. ISPE has taken a leadership role in engaging with regulators in key areas such as drug shortages and quality metrics. I am enthusiastic about other recent efforts such as Women in Pharma and Industry Young Professionals, which are part of our strategic initiatives.”

Arnold has been a member of ISPE for more than 18 years serving as leader of the Investigational Products Community of Practice, Chair of the Knowledge Network Council, Chair of the Strategic Forum, and as a Board Officer for the past three years. He is also a member of the Global Pharmaceutical Manufacturers Leadership Forum (GPMLF). In 2011, Arnold was awarded ISPE’s Volunteer of the Year Award.

Representing both ISPE and Pfizer, Arnold introduced keynote speaker Nicole Pierson at the ISPE Annual Meeting & Expo in Atlanta on 19 September. Pierson is the mother of 10-year-old Gavin Pierson, a brain tumor survivor who was the first pediatric patient to take Pfizer’s palbociclib, which was in the clinical trial stage at the time and was made available to Gavin on a compassionate use request. Arnold told the audience, “you are all heroes for the work you do and for providing hope to millions of patients around the world.”

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The more than 18,000 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Bethesda, Maryland, USA, and an operations and training center in Tampa, Florida, USA. Visit http://www.ISPE.org for more information.

For more information, contact:
Maria Robertson
Senior Director, Marketing Communications
International Society for Pharmaceutical Engineering (ISPE)
Tel: +1-301-364-9207
Email: mrobertson(at)ispe(dot)org
http://www.ISPE.org

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Maria Robertson
ISPE
+1 813-960-2105 Ext: 404
Email >
Visit website